NUNABIO LIMITEDActive

Company number 08093593Private limited companyIncorporated 2012

Key figures

£2,523,593+726.1%
Net assets 2025
+99.9%
Average annual growth 2021–2025
-1 m01 m2 m3 m20212022202320242025

Like most small UK companies, NUNABIO LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m20212022202320242025
Filed accounts2021–2025
20212022202320242025
Cash at bank and in hand108,08165,3611,539,117481,9812,030,246
Total assets175,291111,3672,215,055——
Total liabilities17,188106,424———
Net assets / total equity158,1034,9431,083,279-403,0372,523,593
Average number of employees810121718

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the Company was that of Synthetic DNA production.

As described in the company's latest filed accounts.

Summary: NUNABIO LIMITED

Company

NUNABIO LIMITED is a private limited company registered with Companies House under company number 08093593. It was incorporated on 6 Jun 2012. Its status is active. The registered office is in Newcastle upon tyne (NE1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), other research and experimental development on natural sciences and engineering (72190), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £2,523,593, up 726.1% on the previous year. Cash at bank and in hand was £2,030,246. The company had an average of 18 employees. Figures are available for 5 financial years (2021–2025).

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 20 Jun 2027.